Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients

201437 citationsJournal Articlegold Open Access

Authors

Joanna Szkandera · Medical University of Graz

Armin Gerger · Medical University of Graz

Bernadette Liegl‐Atzwanger · Medical University of Graz

Michael Stotz · Medical University of Graz

Hellmut Samonigg · Medical University of Graz

Ferdinand Ploner · Medical University of Graz

Tatjana Stojaković

Abstract

The present data underline a negative prognostic impact of low pre-operative Hb levels on clinical outcome in STS patients. Thus, Hb levels may provide an additional and cost-effective tool to discriminate between STS patients that are at high risk of mortality.

Topics & Keywords

Urologic and reproductive health conditions Sarcoma Diagnosis and Treatment Genital Health and Disease

Publication Details

Published in: PLoS ONE

Volume 9, Issue 9, pp. e107297-e107297

DOI: 10.1371/journal.pone.0107297

Field-Weighted Citation Impact: 2.55

Command Palette

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients

Authors

Abstract

Topics & Keywords

Publication Details